As experts revise the guideline on management of chronic inflammatory demyelinating polyneuropathy, some in the clinical neurology field are calling for a regrouping of CIDP under a more general, overarching term, “CIDP syndrome” (CIDPS).

Electrodiagnostic testing frequently provides important information when evaluating patients with suspected peripheral neuropathy, based on a retrospective look at real-world data.

Recent studies have identified diagnostic pitfalls.

When a patient presents with polyneuropathy and progressive or relapsing symptoms such as tingling, proximal weakness, and absent reflexes, the clinician should consider a diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP), according to the National Institutes of Health. Confirming the diagnosis requires further testing, however.